165 related articles for article (PubMed ID: 37040401)
1. ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.
Mayro B; Hoj JP; Cerda-Smith CG; Hutchinson HM; Caminear MW; Thrash HL; Winter PS; Wardell SE; McDonnell DP; Wu C; Wood KC; Pendergast AM
Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2210418120. PubMed ID: 37040401
[TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
Li Q; Kluz T; Sun H; Costa M
PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization.
Liu YV; Hubbi ME; Pan F; McDonald KR; Mansharamani M; Cole RN; Liu JO; Semenza GL
J Biol Chem; 2007 Dec; 282(51):37064-73. PubMed ID: 17965024
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY
J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048
[TBL] [Abstract][Full Text] [Related]
7. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
Li YM; Zhou BP; Deng J; Pan Y; Hay N; Hung MC
Cancer Res; 2005 Apr; 65(8):3257-63. PubMed ID: 15833858
[TBL] [Abstract][Full Text] [Related]
8. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.
Koshiji M; Kageyama Y; Pete EA; Horikawa I; Barrett JC; Huang LE
EMBO J; 2004 May; 23(9):1949-56. PubMed ID: 15071503
[TBL] [Abstract][Full Text] [Related]
10. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression.
Bárdos JI; Chau NM; Ashcroft M
Mol Cell Biol; 2004 Apr; 24(7):2905-14. PubMed ID: 15024078
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha.
Hur E; Chang KY; Lee E; Lee SK; Park H
Mol Pharmacol; 2001 May; 59(5):1216-24. PubMed ID: 11306706
[TBL] [Abstract][Full Text] [Related]
13. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.
Liu YV; Semenza GL
Cell Cycle; 2007 Mar; 6(6):656-9. PubMed ID: 17361105
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.
Hammer S; To KK; Yoo YG; Koshiji M; Huang LE
Cell Cycle; 2007 Aug; 6(15):1919-26. PubMed ID: 17671423
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.
Mottet D; Dumont V; Deccache Y; Demazy C; Ninane N; Raes M; Michiels C
J Biol Chem; 2003 Aug; 278(33):31277-85. PubMed ID: 12764143
[TBL] [Abstract][Full Text] [Related]
16. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
18. TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis.
Zhang L; Cao J; Dong L; Lin H
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13447-13456. PubMed ID: 32482854
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.
Shi YH; Wang YX; Bingle L; Gong LH; Heng WJ; Li Y; Fang WG
J Pathol; 2005 Mar; 205(4):530-6. PubMed ID: 15714461
[TBL] [Abstract][Full Text] [Related]
20. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
